NICEATM Support of Tox21

https://ntp.niehs.nih.gov/go/791011

NICEATM conducted the following Tox21 projects. Full descriptions of those projects.

Use of high throughput assays and computational models to replace current Tier 1 Endocrine Disruptor Screening Program (EDSP) tests.
Validation of high throughput screening estrogen receptor transactivation assay.
Development of a reference database for estrogenic and androgenic activity.
In vitro to in vivo extrapolation using Tox21 data.
Evaluation of Tox21 data for predicting acute oral toxicity.
Development of domain-specific, quantitative structure-activity relationship (QSAR) models to predict estrogen receptor binding and activity.
Development of a computational model for androgen receptor pathway activity.
Development of QSAR models to predict androgen receptor binding and activity.
Development of a bioactivity-based read-across approach.
Analysis of the NTP-provided 52 compounds in the EPA ToxCast Phase II program.

Related Annual Report Pages:

"ICCVAM Activities ..." - previous article

Annual Report for Fiscal Year 2015